A Novel Approach to Cancer Therapy Using an Oncolytic Herpes Virus to Package Amplicons Containing Cytokine Genes
Open Access
- 30 September 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (3) , 250-256
- https://doi.org/10.1006/mthe.2001.0448
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diverse Stabilities of Expression in the Rat Brain from Different Cellular Promoters in a Helper Virus-Free Herpes Simplex Virus Type 1 Vector SystemHuman Gene Therapy, 1999
- Selective Infection and Cytolysis of Human Head and Neck Squamous Cell Carcinoma with Sparing of Normal Mucosa by a Cytotoxic Herpes Simplex Virus Type 1 (G207)Human Gene Therapy, 1999
- Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor ImmunityHuman Gene Therapy, 1999
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- Minutes from the March 6–7, 1997 Recombinant DNA Advisory Committee MeetingHuman Gene Therapy, 1997
- Helper Virus-Free Herpes Simplex Virus-1 Plasmid Vectors for Gene Therapy of Parkinson's Disease and Other Neurological DisordersExperimental Neurology, 1997
- Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.Journal of Clinical Investigation, 1997
- Rapid Production of Interleukin-2-Secreting Tumor Cells by Herpes Simplex Virus-Mediated Gene Transfer: Implications for Autologous Vaccine ProductionHuman Gene Therapy, 1996
- Defective HSV-1 Vector Expressing BDNF in Auditory Ganglia Elicits Neurite Outgrowth: Model for Treatment of Neuron Loss Following Cochlear DegenerationHuman Gene Therapy, 1996
- The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vectorCell, 1982